As of Jul 2, 2026, the MLAB stock has a PE ratio of 86.51. The calculation is based on the latest EPS of $1.22 and the stock price of $105.54 per share.
The mean historical PE ratio of Mesa Laboratories over the last ten years is 262.15. The current 86.51 P/E ratio is 67% lower than the historical average. Looking back at the last ten years, MLAB's PE ratio peaked in the Mar 2023 quarter at 1,027.82, with a price of $174.73 and an EPS of $0.17. The Sep 2016 quarter marked the lowest point at 38.25, with a price of $114.36 and an EPS of $2.99.
Maximum annual increase: 355.38% in 2020
Maximum annual decrease: -31.46% in 2021
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2026 | 72.48 | N/A | $88.42 | $1.22 |
| 2025 | N/A | N/A | $118.66 | -$0.36 |
| 2024 | N/A | N/A | $109.73 | -$47.2 |
| 2023 | 1,027.82 | 45.17% | $174.73 | $0.17 |
| 2022 | 708 | 91.9% | $254.88 | $0.36 |
| 2021 | 368.94 | -31.46% | $243.5 | $0.66 |
| 2020 | 538.31 | 355.38% | $226.09 | $0.42 |
| 2019 | 118.21 | N/A | $230.5 | $1.95 |
| 2018 | N/A | N/A | $148.44 | -$0.79 |
| 2017 | 40.36 | 29.86% | $122.7 | $3.04 |
| 2016 | 31.08 | 17.11% | $96.35 | $3.1 |
| 2015 | 26.54 | -23.25% | $72.2 | $2.72 |
| 2014 | 34.58 | 65.14% | $90.25 | $2.61 |
| 2013 | 20.94 | 2.35% | $52.78 | $2.52 |
| 2012 | 20.46 | 35.68% | $49.32 | $2.41 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 72.48 | -38.14% | $88.42 | $1.22 |
| Dec 2025 | 117.16 | N/A | $78.5 | $0.67 |
| Sep 2025 | N/A | N/A | $67.01 | -$0.3 |
| Jun 2025 | N/A | N/A | $94.22 | -$0.12 |
| Mar 2025 | N/A | N/A | $118.66 | -$0.36 |
| Dec 2024 | N/A | N/A | $131.87 | -$46.31 |
| Sep 2024 | N/A | N/A | $129.86 | -$45.61 |
| Jun 2024 | N/A | N/A | $86.77 | -$46.47 |
| Mar 2024 | N/A | N/A | $109.73 | -$47.2 |
| Dec 2023 | 616.29 | N/A | $104.77 | $0.17 |
| Sep 2023 | N/A | N/A | $105.07 | -$0.14 |
| Jun 2023 | 377.94 | -63.23% | $128.5 | $0.34 |
| Mar 2023 | 1,027.82 | N/A | $174.73 | $0.17 |
| Dec 2022 | N/A | N/A | $166.21 | -$0.28 |
| Sep 2022 | N/A | N/A | $140.83 | -$0.75 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of MLAB is lower than its 5 and 10-year averages.
Mesa Laboratories's price to earnings (P/E) of 86.51 is higher than the Technology sector, the industry and its peers average. In comparison with the Technology sector average of 37.27, Mesa Laboratories's price to earnings (P/E) is 132% higher.
In comparison to its peer stocks GE and TMO, MLAB's PE ratio is higher. Mesa Laboratories's PE ratio is trading above the peer average of 34.42.
| Stock name | PE ratio | Market cap |
|---|---|---|
| STE STERIS plc | 27.38 | $21.3B |
| TMO Thermo Fisher Scientific Inc | 28.73 | $194.52B |
| MMM 3M Co | 30.74 | $83.68B |
| AME Ametek Inc | 35.39 | $53.78B |
| DHR Danaher Corp | 38.14 | $140.09B |
| GE General Electric Co | 46.15 | $393.88B |
| MLAB Mesa Laboratories Inc | 86.51 | $583.1M |
| HBIO Harvard Bioscience Inc | N/A | $27.74M |
| BRKR Bruker Corp | N/A | $9.38B |
| RMTI Rockwell Medical Inc | N/A | $21.87M |
| ANGO Angiodynamics Inc | N/A | $540.86M |
MLAB's price to earnings ratio is 86.51 as of Jul 2, 2026.
The 5-year average price to earnings ratio for MLAB stock is 430.1.
Over the last ten years, the Mar 2023 quarter recorded the highest quarterly PE ratio at 1,027.82.
MLAB's current price to earnings ratio is 67% below its 10-year historical average.
MLAB's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jul 2, 2026), Mesa Laboratories's share price is $105.54. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $1.22. Therefore, Mesa Laboratories's PE ratio for today is 86.51. PE RATIO(86.51) = STOCK PRICE($105.54) / TTM EPS($1.22)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.